Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S12 pseudogene 18 (RPS12P18) is a processed pseudogene corresponding to the ribosomal protein S12 gene, present in the human genome but lacking protein-coding function[1][2][6]. Pseudogenes like RPS12P18 are classified as non-functional DNA sequences resulting from retrotransposition or duplication of functional ribosomal protein genes; they are typically not transcribed into functional products and do not have a role as therapeutic targets or involvement in known biological processes or diseases[1][2][6]. Explanation and context: RPS12P18 is not a functional protein-coding gene; it is a processed pseudogene—a type of genomic sequence similar to a functional gene but rendered non-functional due to mutations or lack of regulatory elements[1][2][6]. There is no evidence that pseudogenes like RPS12P18 act as enzymes, receptors, transporters, or therapeutic targets, nor are they known to serve as biomarkers, have interacting drugs, or known safety/therapeutic challenges[1][2][6]. Its aliases reflect alternate database identifiers or locations, but all refer to the same non-functional, non-coding genomic entity[1][2]. The names “RPS12P19,” “RPS12_8_1068,” and “RPS12_9_1069” are alternative identifiers and do not denote additional functions or significance[2]. There is no indication in the scientific or clinical literature that this pseudogene has biological activity, a role in disease, or therapeutic significance, nor does it encode a product that interacts with drugs or acts in cell signaling, regulation, or other well-defined functional pathways[1][2][6]. Its classification is best captured as “Other” within molecular classifications, specifically “processed pseudogene,” and it should not be considered a biologically relevant or actionable target. In summary, RPS12P18 is a non-coding, non-functional pseudogene of the ribosomal protein S12 family and not a legitimate molecular target for therapeutic, diagnostic, or research purposes[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S12 pseudogene 18 (RPS12P18).